genetics

GSK bets $300 million on genetics as CEO plays down break-up talk

London, July 27, 2018: GlaxoSmithKline aims to turbo-charge its drug discovery engine with a big bet on genetics as its…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420